APRE - Aprea Therapeutics GAAP EPS of -$1.34 May, 15 2023 05:05 PM Aprea Therapeutics Inc. 2023-05-15 17:05:23 ET Aprea Therapeutics press release ( NASDAQ: APRE ): Q1 GAAP EPS of -$1.34. As of March 31, 2023, the Company reported cash and cash equivalents of $31.0 million. For further details see: Aprea Therapeutics GAAP EPS of -$1.34